Molecular Gate

Barcelona, Spain

Molecular Gate refer to an innovative class of small-molecule drugs developed by Gate Bioscience.

$526K raised

Mar 2026

Seed

Biotechnology Life Science Pharmaceutical

Top Investors

CDTI Innovación's INNVIERTE programBeAble Capital

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Molecular Gate

How much funding has Molecular Gate raised?

Molecular Gate has raised $526K in total funding. The most recent round was Seed. The last funding was announced in March 2026.

Who are Molecular Gate's investors?

Molecular Gate's investors include CDTI Innovación's INNVIERTE program, BeAble Capital.

Where is Molecular Gate headquartered?

Molecular Gate is headquartered in Barcelona, Spain.

What does Molecular Gate do?

Molecular Gate refer to an innovative class of small-molecule drugs developed by Gate Bioscience.

What stage is Molecular Gate at?

Molecular Gate is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 2, 2026.

MLA

"Molecular Gate — Funding & Investors." VCBacked, March 2, 2026, https://www.vcbacked.co/company/molecular-gate. Accessed June 4, 2026.

APA

VCBacked. (2026). Molecular Gate — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/molecular-gate

Wikipedia (cite web)

{{cite web |title=Molecular Gate — Funding & Investors |url=https://www.vcbacked.co/company/molecular-gate |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 2, 2026.

Similar Companies in Biotechnology